Benitec Biopharma (BNTC) Competitor Comparison
We are evaluating the key criteria listed to compare Benitec Biopharma (BNTC) against its competitors in the Biotechnology industry.
Market Capitalization
341 / 368Gross Profits
148 / 278Total Revenue
274 / 300EBITDA
85 / 337Free Cashflow
98 / 352Quick Ratio
169 / 357Earnings per Share
306 / 359Dividend yield
0 / 6Total Cash
292 / 358Performance 3 years
229 / 368Performance 5 years
270 / 368Performance 10 years
341 / 368Linearity 3 years
289 / 368Linearity 5 years
261 / 368Linearity 10 years
310 / 367Total Rank
295 / 368Dividend Rank
58 / 368Valuation Rank
337 / 368Piotroski Rank
259 / 368Muliplier Rank
291 / 368Market Capitalization - BNTC ranking 341 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.